Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul;29(4):e199-e201.
doi: 10.1097/IPC.0000000000001063. Epub 2021 Jul 8.

Tocilizumab and SARS-CoV-2 (COVID-19): An Evolving Story, the Picture Is Clearer

Larry M Bush  1   2 , Justin Williams  3 , Evan Stutchin  3
Affiliations
Editorial

Tocilizumab and SARS-CoV-2 (COVID-19): An Evolving Story, the Picture Is Clearer

Larry M Bush et al. Infect Dis Clin Pract (Baltim Md). 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

References

    1. Pairo-Castineira E Clohisey S Klaric L, et al. . Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92–98. - PubMed
    1. de Leeuw AJM Oude Luttikhuis MAM Wellen AC, et al. . Obesity and its impact on COVID-19. J Mol Med (Berl). 2021;1–17. - PMC - PubMed
    1. Beigel JH Tomashek KM Dodd LE, et al. ACTT-1 Study Group Members . Remdesivir for the treatment of COVID-19—final report. N Engl J Med. 2020;383:1813–1826. - PMC - PubMed
    1. RECOVERY Collaborative Group, Horby P Mafham M Linsell L, et al. . Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383:2030–2040. - PMC - PubMed
    1. Janiaud P Axfors C Scmitt AM, et al. . Association of convalescent plasma treatment with clinical outcomes in patients with Covid-19. A systemic review and meta-analysis. JAMA. 2021;325:1185–1195. - PMC - PubMed

Publication types